$3.02
-0.06-1.95%
At close: -
$3.03
0.010.38%
After Hours: Jan 31, 7:04 PM EDT
Aquestive Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aquestive Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-04 | $-0.13 | $-0.13 | 0.00 % |
Q2 | 2024-08-06 | $-0.03 | $-0.12 | 75.0 % |
Q1 | 2024-05-07 | $-0.17 | $-0.08 | -112.5 % |
Q4 | 2024-03-05 | $-0.10 | $-0.08 | -25.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-04 | $13.54M | $12.68M | 6.80 % |
Q2 | 2024-08-06 | $20.10M | $12.38M | 62.4 % |
Q1 | 2024-05-07 | $12.05M | $12.26M | -1.69 % |
Q4 | 2024-03-05 | $13.21M | $11.63M | 13.6 % |
Aquestive Therapeutics (AQST) is scheduled to report earnings on March 4, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
The Actual EPS was $-0.13, which hit the estimate of $-0.13.
The Actual Revenue was $13.5M, which beat the estimate of $12.7M.
Browse earnings estimates, EPS, and revenue on all stocks.